3 Profitable Healthcare Stocks That Are Trouncing the Market During the Coronavirus CorrectionThe Motley Fool • 03/10/20
Gilead Sciences' Acquisition Of Forty Seven Was A Wise Move, CD47 Space Is Key Future Cancer TargetSeeking Alpha • 03/09/20
February Portfolio Update: 8% Outperformance With Strong Predictions, Careful With New PurchasesSeeking Alpha • 03/09/20
Gilead Surges To 3-Year High On Expectations For Speedy Coronavirus DrugInvestors Business Daily • 03/06/20